Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS.

Ouali Alami N, Schurr C, Olde Heuvel F, Tang L, Li Q, Tasdogan A, Kimbara A, Nettekoven M, Ottaviani G, Raposo C, Röver S, Rogers-Evans M, Rothenhäusler B, Ullmer C, Fingerle J, Grether U, Knuesel I, Boeckers TM, Ludolph A, Wirth T, Roselli F, Baumann B.

EMBO J. 2018 Jun 6. pii: e98697. doi: 10.15252/embj.201798697. [Epub ahead of print]

2.

Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.

Siewert C, Moog R, Alex R, Kretzer P, Rothenhäusler B.

Eur J Pharm Sci. 2018 Mar 30;115:126-131. doi: 10.1016/j.ejps.2017.12.022. Epub 2017 Dec 24.

PMID:
29278757
3.

Time domain NMR as a new process monitoring method for characterization of pharmaceutical hydrates.

Schumacher SU, Rothenhäusler B, Willmann A, Thun J, Moog R, Kuentz M.

J Pharm Biomed Anal. 2017 Apr 15;137:96-103. doi: 10.1016/j.jpba.2017.01.017. Epub 2017 Jan 9.

PMID:
28107690
4.

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.

Soethoudt M, Grether U, Fingerle J, Grim TW, Fezza F, de Petrocellis L, Ullmer C, Rothenhäusler B, Perret C, van Gils N, Finlay D, MacDonald C, Chicca A, Gens MD, Stuart J, de Vries H, Mastrangelo N, Xia L, Alachouzos G, Baggelaar MP, Martella A, Mock ED, Deng H, Heitman LH, Connor M, Di Marzo V, Gertsch J, Lichtman AH, Maccarrone M, Pacher P, Glass M, van der Stelt M.

Nat Commun. 2017 Jan 3;8:13958. doi: 10.1038/ncomms13958.

5.

Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases.

Nettekoven M, Adam JM, Bendels S, Bissantz C, Fingerle J, Grether U, Grüner S, Guba W, Kimbara A, Ottaviani G, Püllmann B, Rogers-Evans M, Röver S, Rothenhäusler B, Schmitt S, Schuler F, Schulz-Gasch T, Ullmer C.

ChemMedChem. 2016 Jan 19;11(2):179-89. doi: 10.1002/cmdc.201500218. Epub 2015 Jul 21.

PMID:
26228928
6.

Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.

Kuentz M, Rothenhäusler B, Röthlisberger D.

Drug Dev Ind Pharm. 2006 Nov-Dec;32(10):1165-73.

PMID:
17090439
7.
8.

Structural intermediates in the reactions of antigenic peptides with MHC molecules.

Dornmair K, Rothenhäusler B, McConnell HM.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:409-16. No abstract available.

PMID:
2639762

Supplemental Content

Loading ...
Support Center